Aerovate Therapeutics Inc
NASDAQ:AVTE
Balance Sheet
Balance Sheet Decomposition
Aerovate Therapeutics Inc
Aerovate Therapeutics Inc
Balance Sheet
Aerovate Therapeutics Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
4
|
5
|
54
|
22
|
23
|
34
|
|
| Cash |
4
|
5
|
54
|
22
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
23
|
34
|
|
| Short-Term Investments |
0
|
0
|
113
|
107
|
99
|
45
|
|
| Other Current Assets |
0
|
0
|
7
|
2
|
2
|
1
|
|
| Total Current Assets |
4
|
5
|
174
|
132
|
124
|
80
|
|
| PP&E Net |
0
|
0
|
1
|
1
|
1
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
3
|
2
|
0
|
|
| Total Assets |
4
N/A
|
5
+34%
|
175
+3 632%
|
135
-23%
|
127
-6%
|
80
-37%
|
|
| Liabilities | |||||||
| Accounts Payable |
1
|
1
|
1
|
3
|
2
|
0
|
|
| Accrued Liabilities |
0
|
1
|
1
|
5
|
14
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Current Liabilities |
1
|
2
|
3
|
8
|
18
|
4
|
|
| Long-Term Debt |
3
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
2
-44%
|
3
+61%
|
9
+197%
|
18
+109%
|
4
-78%
|
|
| Equity | |||||||
| Common Stock |
4
|
16
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
4
|
13
|
36
|
88
|
163
|
233
|
|
| Additional Paid In Capital |
0
|
0
|
209
|
215
|
273
|
309
|
|
| Other Equity |
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Equity |
0
N/A
|
3
+625%
|
172
+5 845%
|
127
-27%
|
109
-14%
|
76
-30%
|
|
| Total Liabilities & Equity |
4
N/A
|
5
+34%
|
175
+3 632%
|
135
-23%
|
127
-6%
|
80
-37%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
23
|
23
|
24
|
25
|
28
|
29
|
|